Deutsch
0.0
(0)
Available
Cantourage
Grow 20 EU
Euforia
North Macedonia
Available at our partners
On the map
About the strain
Euforia
Euforia, a sativa-dominant strain, originated from a selective Skunk breeding program. This strain was created back in the 90s through the crossbreeding of Skunk #1, Orange Bud, and Skunk #11. Thanks to the dominant terpenes ß-Myrcene, Linalool, α-Pinenee, and ß-Pinenee, Euforia possesses its distinctive "skunky" musky scent, intertwined with fruity aromas. It has a THC content of approximately 18-20%. The euphoric high can provide mental relief, promoting feelings of happiness, relaxation, and tranquility. This can be beneficial for individuals dealing with stress, anxiety, or mood disorders.
Parents:
Skunk #1, Orange Bud, Skunk #11
Terpenes
Alpha-Pinen
Beta-Myrcen
Beta-Pinen
Linalool
Taste
There is no taste reported yet
Reviews
There are not reviews, yet.
FAQ
How secure is Weed.de in terms of protecting patient data and complying with privacy regulations?
Our platform places the highest value on protecting patient data and complying with strict privacy regulations. We employ advanced security technologies and procedures to ensure the confidentiality of your patient data.
How easy is it for me, as a doctor, to integrate into the platform, and how long does it take until I can effectively use it?
Integration into our platform is easy and straightforward. After registration, you will gain access to our user-friendly interface and can effectively utilize the platform. The exact setup time depends on your individual requirements.
What support does Weed.de provide to doctors?
As an independent platform, we connect patients with doctors and pharmacies. Doctors can easily view the inventory of various pharmacies and provide appropriate advice to their patients.
Can I also use the platform on mobile devices?
Yes, we offer a user-friendly app for Android and iOS that allows you to conveniently access the platform from your mobile device. This gives you access to important features and information anytime and anywhere.
Which patients can be prescribed cannabis?
Patients can receive medical cannabis when conventional treatment is unavailable or when the treating physician deems another treatment unsuitable due to side effects and the patient's condition.
In which indications is cannabis effective?
Although cannabis is not approved for any specific indication, it shows promising evidence of positive effects in chronic pain, spasticity in multiple sclerosis, appetite loss, nausea and vomiting, as well as in various other areas such as dermatology, ophthalmology, internal medicine, and psychiatric disorders/symptoms.
Which doctors can prescribe medical cannabis?
In Germany, doctors from any specialty can issue a cannabis prescription, excluding dentists and veterinarians.
How is cannabis prescribed exactly?
Once the doctor has recognized cannabis as a suitable treatment method for the patient, they must complete a BTM prescription (Narcotics Prescription) specifying the quantity, cannabis strain, and dosage. The BTM prescription serves for legal documentation and regulation of the prescribed cannabis, enabling the patient to legally obtain the medicine from a pharmacy.
What challenges exist for the patient?
It is often challenging for patients to find a suitable doctor who listens to them and is open to individualized therapy. Additionally, it can be difficult to find pharmacies that have the required medication in stock.
Account
Newsletter
Don't miss a thing! With our newsletter you will regularly receive exciting information and much more!
Legal and medication information about the information on this site
It is important to us that we can offer you well-researched and informative content. Please note, however, that this is merely a transfer of information and not a concrete recommendation for action. In addition, our articles do not replace a visit to the doctor. You should discuss possible interactions with other medications with your doctor before taking them. Because the cannabinoid tetrahydrocannabinol (THC) is subject to the Narcotics Act (BtMG) in Germany.